Wyeth recruits Charlie's Angel for menopause awareness effort

Share this article:
Former 'Charlie's Angel' Cheryl Ladd is the latest celebrity to sign on to a DTC disease awareness campaign – in this case, urging menopausal women to get checked out and talk to their doctors.
The campaign, by Wyeth, features 30-second TV ads, banner ads, a Web site and PR, and was prompted by research showing a nearly 30 percent drop in the number of women visiting their doctors about menopausal issues over the past three years. Mike Dey, president of women's healthcare at Wyeth, said the company views itself as a leader in women's health and feels a responsibility to raise awareness of the issues facing menopausal women, which number 40 million in the U.S.
"It's our belief that this is an important time for women to see their healthcare provider," said Dey, "because there are less obvious changes that occur more frequently around the time of menopause, like osteoporosis, heart disease, diabetes and depression."
Wyeth markets the Premarin and Prempro hormone replacement therapy brands, though neither brand appears in the spots, nor do they push HRT. Wyeth's corporate branding does appear throughout the campaign.
Advertising is being handled by Ogilvy Healthworld, with PR by Ketchum and interactive by Medical Broadcasting Company. Ladd took part in a radio and satellite media tour and will feature in a series of events, discussing her experience with menopause, as she does on the campaign's Web site, TalkingToYourDoctor.com. The site also features tips on talking to physicians about menopause and a symptom assessor, along with information on other pertinent health topics.
Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.